Page 3 - Best Immunotherapy doctors: TOP 83 doctors

Dr. Amir specializes in targeted therapy with Keytruda (Pembolizumab) for breast cancer, with over 30 presentations at scientific meetings.

• Recipient of multiple awards, including ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)
• Fellowship in Breast Cancer Research at Emory University
• Over 19 years of experience of experience in oncology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Dr. Salman specializes in immunotherapy for various cancers, integrating targeted therapies and cancer vaccines. He trained at prestigious institutions like Memorial Sloan Kettering Cancer Center.

• Associate Professor at Katip Çelebi University with 32 years of experience in medical oncology
• Academic visitor at Moffitt Cancer Center in Florida, USA
• Board member of Turkish Society of Medical Oncology and European Society of Medical Oncology
• Uses comprehensive genomic profiling for personalized treatment plans
• Active in clinical research and experimental medical therapies

Assoc. Prof. Nail Paksoy specializes in immunotherapy at Medipol Bahçelievler Hospital, with a strong background in medical oncology and allergy-immunology.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials for immunotherapy
• Published multiple studies on cancer treatment outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Ozden specializes in medical oncology with over 27 years of experience of experience in internal medicine and oncology.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced internal medicine at multiple hospitals in Turkey
• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine

Professor of Medical Oncology with over 29 years of experience of experience, specializing in advanced cancer treatments at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Associate Professor and later Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Atakan Topcu specializes in immunotherapy and targeted therapies for solid tumors at Medipol Acibadem District Hospital.

• Published over 50 scientific articles in oncology
• Member of European Society for Medical Oncology (ESMO)
• Expert in geriatric oncology and cancer-related malnutrition
• Fellowship-trained in medical oncology at Bezmialem Vakıf University

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic, specializing in blood disorder treatment with over 36 years of experience of practice.

• One of the top doctors for non-Hodgkin lymphoma
• Professor with extensive academic and clinical expertise
• Focuses on immunotherapy for blood disorders

Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for multiple cancer types at Medipol Acibadem District Hospital.

• Trained at top institutions including Cleveland Clinic and Harvard Medical School
• ESMO Board Certified – recognized expertise in oncology
• International observership at Italy's leading breast cancer unit
• Fellowship-trained medical oncologist with broad cancer experience

Dr. Lucía González Cortijo leads one of Spain's top oncology departments, specializing in immunotherapy for breast and gynecologic cancers.

• 20+ years focused exclusively on oncology
• Principal investigator in 20+ immunotherapy clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Active member of ESMO and ASCO
• Leads La Vida en Rosa Foundation for women's cancer support

World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.

• Specializes in lymphomas and CLL with innovative treatment approaches
• Head of Hematology at IOB Institute of Oncology
• Published 100+ articles in top journals like NEJM and Nature Medicine
• Professor of Hematology at Vall d'Hebron University Hospital

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.

• Key participant in trials leading to Pembrolizumab and Nivolumab-Ipilimumab approvals
• Specializes in overcoming hormone therapy resistance in breast cancer
• Active researcher in phase 1-3 clinical trials for new treatments
• Member of Vall d'Hebron's specialized Breast Cancer and Melanoma Units

Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.

• 44 years of experience specializing in neuro-oncology and immunotherapy complications
• Identified antibodies now used worldwide for diagnosing autoimmune neurological disorders
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Fellowship-trained at Memorial Sloan-Kettering Cancer Center

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in immunotherapy for cancer treatment.

• 15 years of experience of experience in medical oncology
• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Focuses on immunotherapy for various cancer types

Principal Investigator in clinical trials focusing on immunotherapy for gynecological cancers – Dr. Oaknin leads cutting-edge research at Hospital Quiron Barcelona.

• Specializes in ovarian, cervical, and endometrial cancer treatments
• Author of over 100 publications and presentations
• Executive board member of GEICO Group
• Faculty member for Gyn-Track in ESMO